CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-10 | Cancelmo Peter B | Grant or award · Stock Option(Right to Buy) | +20,000 | 20,000 | ||
| 2019-06-07 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-07 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-07 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-07 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-07 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-07 | Aspiri Ray Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-07 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +10,000 | $6.05 | $61K | 210,645 |
| 2019-06-07 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Righ to Buy) | −10,000 | 43,996 | ||
| 2019-02-09 | Bumol Thomas F. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-02-08 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2019-02-08 | JACOBSEN MICHAEL A VP Finance and CAO | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2019-02-08 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +425,000 | 425,000 | ||
| 2018-08-31 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +7,529 | $4.10 | $31K | 200,174 |
| 2018-08-31 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −2,192 | $25.31 | $55K | 197,982 |
| 2018-08-31 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −5,337 | $25.93 | $138K | 192,645 |
| 2018-08-31 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +8,000 | $6.05 | $48K | 200,645 |
| 2018-08-31 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −7,529 | 0 | ||
| 2018-08-31 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −8,000 | 53,996 | ||
| 2018-08-30 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +35,000 | $4.10 | $144K | 227,645 |
Page 11 of 20 · 391 trades